about
Targeting cancer using KAT inhibitors to mimic lethal knockoutsCentrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM.Practical Bioinformatics Analysis of MiRNA Data Using Online Tools.Centriole separation in DNA damage-induced centrosome amplification.Rational design and validation of a Tip60 histone acetyltransferase inhibitor.Loss of Ikappa B-beta is associated with prolonged NF-kappa B activity in human glial cells.Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesisDNA damage induces Chk1-dependent centrosome amplification.ROCK activity and the Gβγ complex mediate chemotactic migration of mouse bone marrow-derived stromal cellsAntiinflammatory effects of glucocorticoids in brain cells, independent of NF-kappa B.The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification.DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2.Ku70 prevents genome instability resulting from heterozygosity of the telomerase RNA component in a vertebrate tumour line.Quantifying Tip60 (Kat5) stratifies breast cancerClinically Applicable Inhibitors Impacting Genome StabilityQuantifying Argonaute 2 (Ago2) expression to stratify breast cancer
P50
Q26741346-AF8234B2-B973-4282-B6CB-5D88DC0B1640Q31111156-EE26A082-A556-4A17-A282-97FBE7D19A42Q31141560-386BCE25-DEBA-4B4B-92BA-46801AE9D8D3Q33416534-C6BD38B7-93CA-49DA-A103-5B7B3BEAD584Q33781138-5DC35941-AAC3-417E-BB22-A38B6939D107Q33918655-7FCE1EB0-3A69-4C69-904A-C41EADB75B32Q34076936-87FF2551-B886-4570-AC5D-3BEFED35F7F7Q36029906-B2681E30-0CA8-4FEC-9A42-6663C9890FE4Q36156868-7B788737-2C4B-4BBA-9D1B-7087852ABA7CQ38321863-97BEEA74-DDD2-4133-BD59-056404181E70Q38355683-0B1F3381-B595-469C-824B-0BCEC6C809CBQ39675496-063E3178-AEF0-4137-A688-1D4678A1DAA6Q39786213-B6756B66-71D6-4137-A67F-2D346FDAB12BQ40007798-3ECF84CB-8A78-4006-AC78-7482B0617C41Q64054689-9804C582-4E7C-4237-8DA0-E3FF92C078D8Q88661083-3E82E4E0-A5E0-45CE-8A90-D1F0B9AA6156Q92029647-B0636E74-2BA2-4998-AF29-FEAC65AE5BEE
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2218-3114
@en
name
Emer Bourke
@ast
Emer Bourke
@en
Emer Bourke
@es
Emer Bourke
@nl
type
label
Emer Bourke
@ast
Emer Bourke
@en
Emer Bourke
@es
Emer Bourke
@nl
prefLabel
Emer Bourke
@ast
Emer Bourke
@en
Emer Bourke
@es
Emer Bourke
@nl
P106
P31
P496
0000-0002-2218-3114